FDA Inspection 1216544 — Indrayani Hospital And Cancer Institute

Indrayani Hospital And Cancer Institute — FEI 3017399141

The FDA completed an inspection of Indrayani Hospital And Cancer Institute on Aug 11, 2023 in Alandi Devachi. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Aug 11, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Alandi Devachi (India)

Additional Details

Clinical BA/BE

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.